肝细胞癌中成纤维细胞活化蛋白高表达:CT影像特征与组织学特点
该回顾性多中心研究纳入1197例肝细胞癌手术患者,分析高成纤维细胞活化蛋白(FAP)表达的CT影像特征。延迟期中央强化和血管扩张是高FAP表达的独立预测因素,预测模型训练组AUC为0.779、外部验证组AUC为0.766。高FAP组更高频出现高级别瘤内纤维化和血管包绕肿瘤簇模式。
要点
- 延迟期中央强化预测高FAP表达(OR 15.196,95%CI 8.996-25.670,P<0.001)。
- 血管扩张预测高FAP表达(OR 7.455,95%CI 4.928-11.277,P<0.001)。
- 预测模型识别高FAP的AUC训练组0.779、外部验证组0.766。
核心结论
- 延迟期中央强化和血管扩张是肝细胞癌高FAP表达的独立因素,无创识别FAP表达可能提供预后和治疗方面的潜在信息。
研究设计与样本
- 回顾性多中心研究,纳入2013年8月至2023年6月间接受肝切除的肝细胞癌患者1197例,行FAP组织学染色并分为低表达和高表达组,开发并验证基于CT影像特征的预测模型。
关键影像表现/征象
- 延迟期中央强化和血管扩张是高FAP表达的独立预测因素(OR分别为15.196和7.455)。
- 高FAP肝细胞癌较低FAP肝细胞癌更常见高级别瘤内纤维化(54.7% vs 22.4%,P<0.001)。
- 高FAP肝细胞癌较低FAP肝细胞癌更常见血管包绕肿瘤簇模式(52.1% vs 22.6%,P<0.001)。
诊断标准与关键数值
- 预测模型识别高FAP表达的AUC:训练组0.779,外部验证组0.766。
- 延迟期中央强化预测高FAP表达的OR 15.196(95%CI 8.996-25.670,P<0.001)。
- 血管扩张预测高FAP表达的OR 7.455(95%CI 4.928-11.277,P<0.001)。
临床应用与阅片要点
- 基于延迟期中央强化和血管扩张两个CT特征,可无创预测肝细胞癌FAP表达水平。
- 预测低FAP表达组(n=564)较高FAP表达组(n=262)总生存和无复发生存更优或呈改善趋势。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: To clarify computed tomography (CT) imaging features of high fibroblast activation protein (FAP) expression in hepatocellular carcinoma (HCC) and to investigate their correlation to histological characteristics and prognosis.
METHODS: This retrospective multicenter study evaluated patients with HCC who underwent liver resection between August 2013 and June 2023. Histological staining for FAP was performed, and patients were classified into low and high-FAP expression groups. A predictive model was developed and validated to identify FAP expression levels among CT imaging features. Moreover, CT imaging-related histological characteristics were evaluated. With the predictive model, patients in training cohort were stratified into predicted low and high-FAP expression groups. Overall survival (OS) and recurrence-free survival (RFS) were compared accordingly. Besides, propensity score matching (PSM) and inverse probability of treatment weighting (IPTW) analysis were performed, and OS and RFS between the two groups were also compared.
RESULTS: In total, 1197 patients were included (high-FAP HCCs, n=267). Delayed central enhancement (OR: 15.196, 95% CI: 8.996-25.670, P<0.001) and dilated vasculature (OR: 7.455, 95% CI: 4.928-11.277, P<0.001) independently predicted high-FAP expression (AUCs: 0.779, training; 0.766, external validation). Based on these two CT imaging features, intratumoral fibrosis (ITF) and vessel-encapsulating tumor cluster (VETC) pattern were determined. Compared to low-FAP HCCs, high-FAP HCCs were more frequently with high ITF grade (54.7% vs. 22.4%; P<0.001) and VETC pattern (52.1% vs. 22.6%; P<0.001). Patients were divided into predicted low (n=564) and high (n=262) FAP expression groups. The predicted low-FAP group had significantly better or favorable trend toward improved OS and RFS than predicted high-FAP group before (P<0.001, OS and RFS), and after PSM (P=0.009, OS; P=0.005, RFS) and IPTW (P=0.019, OS; P=0.077, RFS).
CONCLUSION: Delayed central enhancement and dilated vasculature are independent factors of high-FAP expression in HCC. Noninvasive identifying FAP expression may offer potential prognostic and therapeutic insights.
引用
- Wang TC, Huang W, Li SX, et al. High Fibroblast Activation Protein Expression in Hepatocellular Carcinoma: CT Imaging Features and Histological Characteristics. Acad Radiol. 2025. PMID: 40254479. doi:10.1016/j.acra.2025.04.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。